
A study of 4,851 nursing home residents linked shared rooms to higher odds of matching MDRO carriage, while universal decolonization was associated with lower concordant carriage across MRSA, ESBL, and VRE.
PLEASANTON, Calif - Thoratec Laboratories Corporation has announced that it will purchase Thermo Cardiosystmes, Inc. for $572 million in newly issued stock. Under the new deal, which is expected to close next year, Thoratec will exchange .835 a newly issued share for each share of Thermo Cardiosystems. Both companies are manufacturers of artificial heart devices. For more information visit www.thoratec.com.






